|
|
News Features
| M | T | W | T | F | S | S |
|---|---|---|---|---|---|---|
| Mar » | ||||||
| 1 | 2 | 3 | ||||
| 4 | 5 | 6 | 7 | 8 | 9 | 10 |
| 11 | 12 | 13 | 14 | 15 | 16 | 17 |
| 18 | 19 | 20 | 21 | 22 | 23 | 24 |
| 25 | 26 | 27 | 28 | 29 | ||
Thanks to the following sponsor of the WHYY Health+Science Desk:
Philadelphia Health Care Trust
WHYY's Behavioral Health news reporting is supported by a grant from The Thomas Scattergood Behavioral Health Foundation
Friday, February 29th, 2008
The environmental dilemma of disposing of old electronic products will be on the increase. WHYY Morning Edition’s Brenda Jorett talked with Mike Weilbacher, science and environment expert who also heads the Lower Merion Conservancy.
Tuesday, February 26th, 2008
A study published this week finds some of the most commonly prescribed antidepressant drugs are no better than a sugar pill. Researchers looked at data submitted to the FDA for the approval of four drugs. Those were prozac, paxil, effexor and serzone, all of which were approved in the 80s and 90s. The study was published in the most recent edition of the journal PLoS Medicine. As WHYY’s Kerry Grens explains, the results don’t necessarily mean antidepressants don’t work.
Friday, February 22nd, 2008
The ethical dilemma of genetic testing of children who may be predisposed to developing breast or ovarian cancer later in life is the focus of a study published in the American Journal of Medical Genetics. Dr. Angela Bradbury was the lead author of the study that recruited interview subjects through the University of Chicago Cancer Risk Clinic. She now directs the Margaret Dyson Family Rish Assessment Program at Fox Chase Cancer Center in Northeast Philadelphia. She talked with WHYY Morning Edition’s Brenda Jorett.
Friday, February 15th, 2008
Researchers at the University of Pennsylvania have teamed up with a Massachusetts company to expand the ways farm animals can be used as pharmaceutical factories. The company, GTC Biotherapeutics, is the first to make a drug that can be milked from genetically engineered dairy goats. The medication is an anti-thrombin drug called ATryn, which is used to treat people with clotting disorders. It’s not the first time animals have been used to made medicines, but their latest technology is pushing the limits of pharmaceutical science. WHYY’s Kerry Grens reports.
Health+Science Podcast